NCT05598606
- Conditions
- Denosumab Allergy, Zoledronic Acid Allergy
- Locations
-
- ShenzhenPH Shenzhen, Guangdong, China
Clinical trial condition
Explore clinical trials studying Denosumab Allergy. Study availability and eligibility vary by location and protocol.
NCT05598606
NCT05415657